MARCHIGNOLI, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 1.214
NA - Nord America 819
EU - Europa 522
AF - Africa 58
SA - Sud America 56
Totale 2.669
Nazione #
US - Stati Uniti d'America 800
CN - Cina 376
SG - Singapore 322
VN - Vietnam 196
IT - Italia 190
KR - Corea 91
HK - Hong Kong 73
GB - Regno Unito 57
IN - India 56
DE - Germania 53
BR - Brasile 42
FR - Francia 42
AT - Austria 35
NL - Olanda 35
JP - Giappone 29
SE - Svezia 24
ZA - Sudafrica 21
RU - Federazione Russa 19
SC - Seychelles 18
BD - Bangladesh 14
IE - Irlanda 14
CI - Costa d'Avorio 13
FI - Finlandia 13
IQ - Iraq 11
CA - Canada 9
BG - Bulgaria 8
CH - Svizzera 8
ID - Indonesia 8
AR - Argentina 6
TH - Thailandia 6
EC - Ecuador 5
MX - Messico 5
TR - Turchia 5
JO - Giordania 4
PH - Filippine 4
PK - Pakistan 4
PL - Polonia 4
SA - Arabia Saudita 4
UA - Ucraina 4
EE - Estonia 3
ES - Italia 3
TW - Taiwan 3
BE - Belgio 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
TG - Togo 2
AO - Angola 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.669
Città #
Singapore 233
Hefei 175
Ashburn 135
Seoul 87
Hong Kong 69
Bologna 61
San Jose 59
Ho Chi Minh City 54
Hanoi 52
Santa Clara 46
Southend 37
Vienna 31
Los Angeles 29
Fairfield 28
Boardman 27
Beijing 26
Dallas 26
Tokyo 24
Chandler 22
Council Bluffs 21
Seattle 19
Bengaluru 18
New York 17
Johannesburg 16
Houston 15
Dublin 14
Lauterbourg 14
Milan 14
Princeton 14
Abidjan 13
Frankfurt am Main 11
Clifton 10
North Bergen 10
Piscataway 10
Shanghai 10
Cambridge 9
Helsinki 9
Rome 9
Redondo Beach 8
Sofia 8
Wilmington 8
Woodbridge 8
Munich 7
Tongling 7
Turin 7
Baar 6
Da Nang 6
Guangzhou 6
Karbala 6
London 6
Naples 6
Phoenix 6
Rimini 6
Ankara 5
Buffalo 5
Denver 5
Dhaka 5
Düsseldorf 5
Haiphong 5
Atlanta 4
Berlin 4
Brooklyn 4
Castel Maggiore 4
Chennai 4
Chicago 4
Hải Dương 4
Jakarta 4
Marshfield 4
Newark 4
Nuremberg 4
Quận Ba 4
San Francisco 4
Shenzhen 4
São Paulo 4
Trento 4
Amman 3
Amsterdam 3
Ann Arbor 3
Biên Hòa 3
Boydton 3
Can Tho 3
Cesena 3
Falkenstein 3
Genoa 3
Hillsboro 3
Lappeenranta 3
Leuna 3
Olalla 3
Padova 3
Paris 3
Phủ Lý 3
Portsmouth 3
Reggio Emilia 3
Riva del Garda 3
Riyadh 3
Toronto 3
Tân Tiến 3
Warsaw 3
Westminster 3
Wuhan 3
Totale 1.744
Nome #
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 259
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 242
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 222
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? 188
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 176
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 176
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 168
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 164
Evidence-based medicine and the problem of healthy volunteers 157
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 151
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 144
Obesity and NAFLD: Same problem? 132
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 128
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 125
NASH: A glance at the landscape of pharmacological treatment 114
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 113
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 44
Totale 2.703
Categoria #
all - tutte 7.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022119 3 12 6 0 8 6 3 8 12 6 35 20
2022/2023156 9 13 6 12 16 8 11 7 39 7 12 16
2023/2024119 16 14 6 4 10 19 2 10 6 19 2 11
2024/2025527 14 33 51 33 58 11 30 33 20 53 51 140
2025/20261.646 216 227 149 171 104 63 128 62 242 104 137 43
Totale 2.703